New Zealand's proposed intergenerational tobacco ban under review

Sep.02.2022
New Zealand's proposed intergenerational tobacco ban under review
New Zealand's proposal for a tobacco ban on those born after 2009 draws concern from vaping advocates.

The submission period for the Smokefree Environments and Regulated Products (Vaping) Amendment Bill in New Zealand has come to a close, and the parliamentary health select committee is now reviewing public feedback. The Aotearoa Vapers Community Advocacy (AVCA) has stated that one aspect that the New Zealand Royal Legal Office needs to carefully examine is the government's proposed ban on intergenerational tobacco use.


The bill restricts the number of retailers permitted to sell tobacco products with the aim of reducing their appeal and addictive nature, and prohibits the sale of tobacco products to anyone born in or after 2009.


The AVCA has agreed in principle with the concept of a ‘smoke-free generation’. However, they are still concerned that this may be excessive. It should not be forgotten that New Zealand's current youth smoking rates are already well below the overall target for a smoke-free New Zealand by 2025, which is fewer than 5% of the population being regular smokers," said Nancy Loucas, co-founder of the AVCA.


She stated that members of the specialized committee need to test whether the intergenerational tobacco ban would promote the already existing black market, let alone inadvertently make smoking more appealing to young people who inherently crave rebellion.


Every adult has the right to make informed choices. Before implementing it, the government needs to ensure that this will be legally established. I am concerned that if a product is banned for a group of people once they reach adulthood, while other adult products like alcohol remain available to them," said Ms. Lucas.


Advocates of electronic cigarettes believe that there is not enough longitudinal research to fully prove that VLNC e-cigarettes can help people quit smoking. Additionally, this could potentially lead to New Zealanders entering the black market or growing their own tobacco.


Internationally, New Zealand has been praised for successfully implementing public health methods to reduce the harms of tobacco. The country's smoking rates have decreased by half in the past decade, mainly due to smokers switching to electronic cigarettes, which significantly reduce harm.


The government's increasing crackdown on tobacco is good news, but it needs to ensure that bans like intergenerational prohibition and VLNC are legally maintained while being monitored globally. New Zealand is leading the way in advocating for electronic cigarettes as an effective tool for quitting smoking," she said.


According to AVCA, members of the Malaysian parliamentary committee will visit New Zealand in September to gain a deeper understanding of the country's Smokefree 2025 ambition and the policies implemented towards achieving this goal.


Malaysia has proposed a ban on tobacco use for anyone born after 2007. However, the Malaysian Health Minister mistakenly wants to include electronic cigarette products. New Zealand understands that providing viable alternative solutions is necessary if an entire generation is to quit smoking. "We hope Malaysian parliamentarians will understand this and make the appropriate amendments during their visit," she said.


The AVCA has stated that New Zealand should have implemented tough measures against tobacco long ago. Despite regulating e-cigarettes in 2020 to limit their variety to three flavors in general retail, thousands of retail stores in New Zealand still offer every tobacco brand for smokers.


New Zealand is set to achieve its smoke-free goal by 2025, thanks to increasingly strict regulations on smoking and the provision of safer nicotine products for adults. According to Nancy Loucas, the government has done relatively well in supporting e-cigarettes.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
According to French anti-tobacco group Générations Sans Tabac, Philip Morris International’s (PMI) IQOS “Curiosity” campaign has drawn attention from public health advocates. The group argues that the campaign uses themes including curiosity, exploration and lifestyle branding that could increase interest among younger audiences. PMI has positioned IQOS as a key part of its smoke-free product strategy, while France maintains strict restrictions on tobacco and nicotine product marketing. The debate highlights ongoing tensions between heated tobacco branding strategies and public health concerns in Europe.
Jul.24
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters reported on July 13, 2026, that India is seeking to dismiss Adani Airports’ legal challenge over nicotine pouch sales at Mumbai International Airport’s duty-free shops. Adani denies wrongdoing and argues that existing drug and cosmetics regulations do not apply to duty-free sales or nicotine pouches.
Innovation
Jul.14 by 2Firsts Perspectives